May 21, 2026
Fractional CEO is not a part-time title - it is a scoped mandate
Biotech boards use “fractional CEO” to mean many things: interim leadership after a departure, pre-raise credibility, integration captain, or simply senior cover while the company searches for a permanent hire. The label matters less than the mandate and the authority the person actually has.
Operator-led fractional executive engagements work when the company needs decisions made - not another strategy deck.
When a fractional CEO beats a full-time search
Strong fit scenarios:
- M&A or financing in flight - Investors and counterparties want a named operator in the room now, not in six months after a search.
- Clinical or regulatory readout - The next 90 days determine financing and partnership options; leadership bandwidth is the constraint.
- Post-acquisition integration - Two cultures, one P&L, and customers who cannot tell the organization is distracted.
- Turnaround - Stakeholders need calm, credible leadership while the plan is reset.
Weak fit scenarios:
- Stable operations with a clear permanent CEO candidate already identified
- “Prestige” board cover without decision rights or access to information
- Undefined scope where the fractional leader is not accountable for outcomes
What to demand from a fractional CEO candidate
- Transaction and capital credibility - Have they raised capital or closed deals at your stage, not only at mega-cap scale?
- Board fluency - Can they run a board through bad news without losing trust?
- Regulatory and commercial realism - Have they launched or partnered products in complex payer environments?
- Exit clarity - Defined handoff to the permanent CEO with documented operating cadence and decisions.
Katogen's fractional executive and board advisory practice is built for these inflection points - selective engagements, operator-led, with Doug Drysdale and aligned advisors.
Fractional vs retained advisory vs project
- Fractional CEO / C-suite - Embedded leadership with decision rights for a defined period.
- Retained advisory - Regular operator access for the CEO and board without day-to-day control.
- Project deliverables - Specific outputs (diligence, integration plan, launch sequencing) with a clear end date.
Many companies combine models - fractional leadership through a transaction, then retained advisory through integration.
Related reading
- Biopharma consulting vs management consulting - when operators beat generalist firms
- Biopharma consulting services overview - all practice areas and how engagements work
To discuss fractional scope for your company, contact Katogen.
